<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2017</study_start_year><condition>Colorectal Cancer</condition><condition>Colonic Neoplasms</condition><data_sharing_plan>IPD Sharing (as of April 2018): Yes</data_sharing_plan><disease>Colorectal Cancer</disease><disease>Colonic Neoplasms</disease><study_type>Observational</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2271350</full_dataset_link><location>Vietnam</location><study_start_month>1</study_start_month><repository>ECRIN MDR</repository><study_status>Completed</study_status></additional><is_claimable>false</is_claimable><name>Research on the Treatment of Metastatic Colon Cancer Patients Treated by FOLFOXIRI</name><description>Colon cancer with metastase in the diagnose time account for one significant rate and has a increasing trend. The treatment result of this patient group rests modest. The biological therapeutic treatment is still expensive for major part of Vietnamese patients. So that, research on a new affordable and efficacious chemotherapy combination for these patients is extremely necessary in our country The purpose of the study is to comment somes clinico-pathology features of metastatic colon cancer patients whose disease was not radically resectable.
The second aim is to Evaluate the treatment result and toxicity of FOLFOXIRI in these patients</description><dates><creation>2017-01-15</creation></dates><accession>2271350</accession><cross_references><ClinicalTrials___gov>NCT03504618</ClinicalTrials___gov></cross_references></HashMap>